Synth Med
Toronto, CA · 1 known investors
Synth-Med develops a drug delivery platform that uses red blood cells to encapsulate therapeutic payloads in nanoparticles and target hard-to-reach tissues, with a lead program delivering a memory-enhancing molecule to the brain for Alzheimer's and other neurodegenerative diseases. The company operates in the biotech and therapeutics sector.
Investors · 1
Frequently asked questions
- What does Synth Med do?
- Synth-Med develops a drug delivery platform that uses red blood cells to encapsulate therapeutic payloads in nanoparticles and target hard-to-reach tissues, with a lead program delivering a memory-enhancing molecule to the brain for Alzheimer's and other neurodegenerative diseases. The company operates in the biotech and therapeutics sector.
- Who are Synth Med's investors?
- Synth Med's investors include Horizons Ventures.
- Where is Synth Med headquartered?
- Synth Med is headquartered in Toronto, CA.